Trial intelligence / Profile preview

Vitamin K2 for Socket Preservation

NCT06707909Phase 4Recruiting

Sponsor
Cairo University
Start
Feb 2025
Primary completion
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of menaquinone in Alveolar bone loss, sponsored by Cairo University. Started Feb 2025; status: recruiting.

02

Drugs

menaquinone
03

Conditions

Alveolar bone loss

Beyond the preview

Go deeper on NCT06707909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06707909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call